Compare BBLG & NXAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBLG | NXAT |
|---|---|---|
| Founded | 2004 | 2023 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 1.2M |
| IPO Year | 2014 | 2023 |
| Metric | BBLG | NXAT |
|---|---|---|
| Price | $0.28 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 409.0K | 148.6K |
| Earning Date | 10-26-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.30 |
| 52 Week High | $4.78 | $1.23 |
| Indicator | BBLG | NXAT |
|---|---|---|
| Relative Strength Index (RSI) | 28.94 | 23.41 |
| Support Level | N/A | N/A |
| Resistance Level | $0.48 | $0.53 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 10.91 | 2.18 |
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Nexus Advanced Technologies Inc pursuing strategic investments, acquisitions, and partnerships across AI infrastructure and technologies. The Company's ideas include opportunities involving data centers, AI compute and GPU infrastructure, and other technologies supporting the development and deployment of artificial intelligence. Nexus seeks to combine access to capital, strategic partnerships, and technology opportunities to build a diversified platform positioned to participate in the continued growth of world-wide AI infrastructure.